|

[177Lu]Lu-PSMA I&T Clinical Trials

3 actively recruiting trials

Also known as: 177Lu-PSMA, PSMA-RLT

Pipeline

Phase 2: 3

Top Sponsors

  • Medical University of Vienna2
  • Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS1

Indications

  • Cancer3
  • Prostate Cancer2
  • Prostate Cancer Recurrent1

Other3 trials

Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST)
Phase 2
Neoadjuvant PSMA-RLT in Oligometastatic PCa
Phase 2
PSMA-RLT in Biochemically Recurrent PCa
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.